|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 07-07 | Race to launch weight-loss pills heats up as smaller players advance | RE |
| 07-07 | Weight-loss drug developers line up to tap lucrative market as competition heats up | RE |
| Market Cap | 137B 120B 111B 103B 195B 13,020B 198B 1,327B 516B 6,426B 515B 504B 22,210B | P/E 2026 * |
11.8x | P/E 2027 * | 12.2x |
|---|---|---|---|---|---|
| Enterprise Value | 186B 163B 150B 139B 265B 17,699B 269B 1,803B 701B 8,735B 700B 685B 30,192B | EV / Sales 2026 * |
3.02x | EV / Sales 2027 * | 3.04x |
| Free-Float |
59.06% | Yield 2026 * |
7.27% | Yield 2027 * | 7.25% |
Last Transcript: Pfizer Inc
| Manager | Title | Age | Since |
|---|---|---|---|
Albert Bourla
CEO | Chief Executive Officer | 64 | 2018-12-31 |
David Denton
DFI | Director of Finance/CFO | 60 | 2022-05-01 |
| Chief Tech/Sci/R&D Officer | - | 2006-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Suzanne Johnson
BRD | Director/Board Member | 68 | 2007-08-31 |
Shantanu Narayen
BRD | Director/Board Member | 62 | 2013-09-26 |
Albert Bourla
CHM | Chairman | 64 | 2019-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +2.96% | +3.01% | +59.87% | +173.31% | 1,102B | ||
| +3.05% | +5.23% | +72.11% | +67.81% | 643B | ||
| -0.04% | +1.20% | +35.72% | +87.93% | 450B | ||
| +0.65% | -2.07% | +27.62% | +22.57% | 336B | ||
| -0.99% | -0.74% | +28.72% | +47.97% | 288B | ||
| -2.98% | +1.18% | -27.86% | -40.73% | 222B | ||
| +0.45% | +1.65% | +25.65% | +68.35% | 199B | ||
| +5.21% | +7.93% | +21.99% | +83.23% | 169B | ||
| -1.39% | +5.14% | +13.68% | +54.43% | 133B | ||
| Average | -0.22% | +2.58% | +28.61% | +62.76% | 393.39B | |
| Weighted average by Cap. | -0.09% | +2.05% | +42.48% | +90.77% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 61.7B 53.99B 49.76B 46.12B 87.55B 5,856B 88.97B 597B 232B 2,890B 232B 227B 9,989B | 59.34B 51.93B 47.86B 44.36B 84.21B 5,632B 85.57B 574B 223B 2,780B 223B 218B 9,607B |
| Net income | 11.07B 9.69B 8.93B 8.28B 15.71B 1,051B 15.96B 107B 41.63B 519B 41.56B 40.66B 1,792B | 10.72B 9.38B 8.64B 8.01B 15.21B 1,017B 15.45B 104B 40.3B 502B 40.23B 39.36B 1,735B |
| Net Debt | 49.3B 43.14B 39.76B 36.85B 69.96B 4,679B 71.09B 477B 185B 2,309B 185B 181B 7,982B | 43.16B 37.77B 34.81B 32.26B 61.24B 4,096B 62.23B 417B 162B 2,022B 162B 159B 6,987B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Select your edition
All financial news and data tailored to specific country editions


















